-
The Future Of Lung Transplantation
Martine Rothblatt is the founder of United Therapeutics and her team developed the pulmonary hypertension medication, Remodulin. Now her ambition is to tackle the organ shortage in America with technology and genetic engineering. Here is an article about how she is putting her goal into action and what it could mean for the future of transplantation.
What are your thoughts about what she is trying to accomplish?
Sorry, there were no replies found.
Log in to reply.